Predicting Parkinson’s: Can Retinal Thickness Unlock Future Cognitive Decline?

A research collaboration between the University of the Basque Country (UPV/EHU) and Biobizkaia suggests employing a readily available, straightforward, and non-invasive method to track neurodegeneration.

When Parkinson’s or another neurodegenerative disease is diagnosed, patients always ask: “And now what? What will happen? What can be expected from the disease?”

For neurologists, however, it is not possible to answer these questions precisely, as “the evolution of patients tends to be very varied: some experience no change over the years, while others end up with dementia or in a wheelchair,” explained Ane Murueta-Goyena, a researcher in the UPV/EHU’s department of Neurosciences.